4 European Projects Found
Searched on 125080 European Projects
FINISHED
European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS)
Start date: Apr 1, 2012, End date: Mar 31, 2017,
Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core symptoms of autism spectrum disorder (ASD). Major obstructions to this include a lack of aetiologically-driven or pathophysiologically-accurate animal models; an absence of tests that indicate efficacy; and reliance of clinical trials on DSM/ICD10 categories wh ...
Read Project
29
Partners Participants
FINISHED
Novel Methods leading to New Medications in Depression and Schizophrenia (NEWMEDS)
Start date: Sep 1, 2009, End date: Feb 28, 2015,
Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are few novel treatments. We think this is because of three major “bottle-necks”: a lack of etiologically-driven or pathophysiologically-accurate animal models; a lack of tests that provide indication of efficacy in healthy volunteers; and the reliance of clinical ...
Read Project
20
Partners Participants
FINISHED
Phantom phenomena: A window to the mind and the brain (PHANTOMMIND)
Start date: Jan 1, 2009, End date: Dec 31, 2014,
Phantom experiences occur in almost all amputees but are among the least understood sensory phenomena. Recently changes in the representation of body maps in the brain were found to be related to phantom pain and it has also been demonstrated that there are great similarities between nonpainful phantoms and bodily illusions such as the rubber hand illusion. This research has also shown that the br ...
Read Project
1
Partner Participant
FINISHED
Development and analysis of polymer based multi-functional bactericidal materials (EMBEK1)
Start date: Aug 1, 2008, End date: Jul 31, 2011,
90% of bacteria are found attached to solid surfaces forming structures (bio-films), that are inaccessible to drugs and antibiotics. These bio-films represent a major problem in European society in both industry and health care. Currently, however, we understand little about how these bio-films form and, more importantly, how they can be prevented. This lack of understanding means that patients of ...
Read Project
